• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统递送的 siRNA 的消除途径。

Elimination pathways of systemically delivered siRNA.

机构信息

Institute of Molecular Medicine, Peking University, Beijing, China.

出版信息

Mol Ther. 2011 Feb;19(2):381-5. doi: 10.1038/mt.2010.266. Epub 2010 Nov 30.

DOI:10.1038/mt.2010.266
PMID:21119623
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3034859/
Abstract

The elimination process of systemically administered small interfering RNA (siRNA) was investigated by using siRNA labeled with an infrared fluorescent dye. A novel siRNA elimination pathway was identified. In this pathway, liver-enriched siRNA is secreted into the gallbladder and then emptied into the intestine. Blocking this pathway resulted in the absence of siRNA fluorescence within the intestine, with greatly enhanced siRNA accumulation in liver and gallbladder at the same time. Furthermore, we demonstrated that delivery carriers play an essential role in siRNA distribution and elimination, highlighting their importance in siRNA therapeutics.

摘要

本研究采用标记有近红外荧光染料的小干扰 RNA(siRNA)来研究其在体内的消除过程。结果发现了一条新的 siRNA 消除途径:富含 siRNA 的肝胆汁排入胆囊,随后排入肠道。该途径阻断后,肠道内几乎检测不到 siRNA 荧光,而同时肝和胆囊中 siRNA 明显蓄积。此外,我们还证明了递送载体在 siRNA 的分布和消除中起着至关重要的作用,这突显了它们在 siRNA 治疗中的重要性。

相似文献

1
Elimination pathways of systemically delivered siRNA.系统递送的 siRNA 的消除途径。
Mol Ther. 2011 Feb;19(2):381-5. doi: 10.1038/mt.2010.266. Epub 2010 Nov 30.
2
Effects of particle size and binding affinity for small interfering RNA on the cellular processing, intestinal permeation and anti-inflammatory efficacy of polymeric nanoparticles.聚合物纳米粒的粒径和与小干扰 RNA 结合亲和力对其细胞内加工、肠道渗透和抗炎效果的影响。
J Gene Med. 2015 Oct-Dec;17(10-12):244-56. doi: 10.1002/jgm.2866.
3
PAMAM Dendrimers as a Delivery System for Small Interfering RNA.PAMAM 树枝状聚合物作为小干扰 RNA 的递送系统。
Methods Mol Biol. 2020;2115:91-106. doi: 10.1007/978-1-0716-0290-4_5.
4
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.经靶向纳米粒系统给药的 siRNA 在人体中 RNAi 的证据。
Nature. 2010 Apr 15;464(7291):1067-70. doi: 10.1038/nature08956. Epub 2010 Mar 21.
5
Development and application of a dual-purpose nanoparticle platform for delivery and imaging of siRNA in tumors.用于肿瘤中siRNA递送与成像的双功能纳米颗粒平台的研发与应用
Methods Mol Biol. 2009;555:1-13. doi: 10.1007/978-1-60327-295-7_1.
6
Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines.口服递送的含硫代缩醛纳米颗粒负载 TNF-α-siRNA 靶向炎症,并抑制肠道中的基因表达。
Nat Mater. 2010 Nov;9(11):923-8. doi: 10.1038/nmat2859. Epub 2010 Oct 10.
7
SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particles.酸降解阳离子纳米水凝胶颗粒介导的体内基因 RNA 干扰。
J Control Release. 2017 Feb 28;248:10-23. doi: 10.1016/j.jconrel.2016.12.006. Epub 2016 Dec 9.
8
Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.通过T7肽修饰的核壳纳米颗粒进行siRNA的全身递送用于乳腺癌的靶向治疗。
Eur J Pharm Sci. 2016 Sep 20;92:39-48. doi: 10.1016/j.ejps.2016.06.020. Epub 2016 Jun 26.
9
A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.一种仿生纳米载体介导的靶向胆固醇偶联 siRNA 递送至肿瘤基因治疗。
Biomaterials. 2012 Dec;33(34):8893-905. doi: 10.1016/j.biomaterials.2012.08.057. Epub 2012 Sep 12.
10
Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo.新型多功能纳米颗粒介导 siRNA 肿瘤递药、体内可视化和治疗性肿瘤消减。
J Control Release. 2011 Jan 20;149(2):111-6. doi: 10.1016/j.jconrel.2010.09.020. Epub 2010 Oct 1.

引用本文的文献

1
Red Blood Cell Membrane Vesicles for siRNA Delivery: A Biocompatible Carrier With Passive Tumor Targeting and Prolonged Plasma Residency.用于小干扰RNA递送的红细胞膜囊泡:一种具有被动肿瘤靶向性和延长血浆驻留时间的生物相容性载体
Int J Nanomedicine. 2025 Mar 15;20:3269-3301. doi: 10.2147/IJN.S504644. eCollection 2025.
2
Advanced siRNA delivery in combating hepatitis B virus: mechanistic insights and recent updates.抗乙型肝炎病毒的高级 siRNA 递呈:机制见解和最新进展。
J Nanobiotechnology. 2024 Nov 30;22(1):745. doi: 10.1186/s12951-024-03004-3.
3
Current State of Therapeutics for HTLV-1.HTLV-1 的治疗现状。
Viruses. 2024 Oct 15;16(10):1616. doi: 10.3390/v16101616.
4
Circ_0008315 promotes tumorigenesis and cisplatin resistance and acts as a nanotherapeutic target in gastric cancer.环状 RNA 0008315 促进胃癌的肿瘤发生和顺铂耐药,并作为一种纳米治疗靶点。
J Nanobiotechnology. 2024 Aug 29;22(1):519. doi: 10.1186/s12951-024-02760-6.
5
A Strategy Utilizing Protein-Protein Interaction Hubs for the Treatment of Cancer Diseases.利用蛋白质-蛋白质相互作用枢纽治疗癌症疾病的策略。
Int J Mol Sci. 2023 Nov 8;24(22):16098. doi: 10.3390/ijms242216098.
6
Using RNA-based therapies to target the kidney in cardiovascular disease.利用基于RNA的疗法靶向治疗心血管疾病中的肾脏。
Front Cardiovasc Med. 2023 Oct 6;10:1250073. doi: 10.3389/fcvm.2023.1250073. eCollection 2023.
7
Advances in siRNA delivery approaches in cancer therapy: challenges and opportunities.在癌症治疗中 siRNA 传递方法的进展:挑战和机遇。
Mol Biol Rep. 2023 Nov;50(11):9529-9543. doi: 10.1007/s11033-023-08749-y. Epub 2023 Sep 23.
8
Membrane-destabilizing ionizable lipid empowered imaging-guided siRNA delivery and cancer treatment.膜去稳定化可电离脂质助力成像引导的siRNA递送及癌症治疗。
Exploration (Beijing). 2021 Sep 1;1(1):35-49. doi: 10.1002/EXP.20210008. eCollection 2021 Aug.
9
Emergence of Small Interfering RNA-Based Gene Drugs for Various Diseases.用于多种疾病的基于小干扰RNA的基因药物的出现。
ACS Omega. 2023 Jun 1;8(23):20234-20250. doi: 10.1021/acsomega.3c01703. eCollection 2023 Jun 13.
10
Nanotechnology-enabled gene delivery for cancer and other genetic diseases.纳米技术助力癌症和其他遗传性疾病的基因传递。
Expert Opin Drug Deliv. 2023 Apr;20(4):523-540. doi: 10.1080/17425247.2023.2200246. Epub 2023 Apr 10.

本文引用的文献

1
Comprehensive analysis of sequence-specific stability of siRNA.siRNA 序列特异性稳定性的综合分析。
FASEB J. 2010 Dec;24(12):4844-55. doi: 10.1096/fj.09-142398. Epub 2010 Aug 23.
2
Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging.通过多模态体内成像测量肿瘤特异性靶向对siRNA纳米颗粒生物分布和疗效的影响。
Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15549-54. doi: 10.1073/pnas.0707461104. Epub 2007 Sep 17.
3
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs.亲脂性小干扰RNA体内递送的机制与优化
Nat Biotechnol. 2007 Oct;25(10):1149-57. doi: 10.1038/nbt1339. Epub 2007 Sep 16.
4
Radiolabeling small RNA with technetium-99m for visualizing cellular delivery and mouse biodistribution.用锝-99m对小RNA进行放射性标记以可视化细胞递送和小鼠体内生物分布。
Nucl Med Biol. 2007 May;34(4):399-404. doi: 10.1016/j.nucmedbio.2007.02.006.
5
PEG conjugated VEGF siRNA for anti-angiogenic gene therapy.聚乙二醇缀合的血管内皮生长因子小干扰RNA用于抗血管生成基因治疗。
J Control Release. 2006 Nov 28;116(2):123-9. doi: 10.1016/j.jconrel.2006.05.023. Epub 2006 Jun 3.
6
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs.化学修饰的小干扰RNA在体内具有强大且持久的抗乙肝病毒活性。
Nat Biotechnol. 2005 Aug;23(8):1002-7. doi: 10.1038/nbt1122. Epub 2005 Jul 24.
7
Biodistribution of 68Ga-labelled phosphodiester, phosphorothioate, and 2'-O-methyl phosphodiester oligonucleotides in normal rats.68Ga标记的磷酸二酯、硫代磷酸酯和2'-O-甲基磷酸二酯寡核苷酸在正常大鼠体内的生物分布。
Eur J Pharm Sci. 2005 Sep;26(1):26-38. doi: 10.1016/j.ejps.2005.04.017.
8
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.通过全身给予修饰的小干扰RNA对内源基因进行治疗性沉默。
Nature. 2004 Nov 11;432(7014):173-8. doi: 10.1038/nature03121.
9
Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells.靶向Lyn激酶的小干扰RNA(siRNA)可诱导原发性及耐药性BCR-ABL1(+)白血病细胞凋亡。
Nat Med. 2004 Nov;10(11):1187-9. doi: 10.1038/nm1127. Epub 2004 Oct 24.
10
Modulation of HIV-1 replication by RNA interference.RNA干扰对HIV-1复制的调控
Nature. 2002 Jul 25;418(6896):435-8. doi: 10.1038/nature00896. Epub 2002 Jun 26.